The cost of at least 350 drugs in the U.S. are expected to rise in 2026, according to a new analysis, despite many of the drugmakers pledging to offer more favorable prices under new Trump administration policies.
About the Author
Discover more from USA NEWS
Subscribe to get the latest posts sent to your email.
